#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Microneedles as a perspective for transdermal therapeutic systems


Authors: Tomáš Wolaschka
Published in: Čes. slov. Farm., 2019; 68, 12-26
Category: Review Articles

Overview

Transdermal Therapeutic Systems (TTS) improve patient compliance especially due to its simple application and long-term action with the need to exchange the system every 12 hours to several days. The advantages also include elimination of first-pass effect, avoidance of gastrointestinal adverse effects, stable drug levels in the blood and simple discontinuation of therapy by patch removing. However, most drugs do not have the appropriate physicochemical properties to achieve therapeutic levels by transdermal application, therefore only a limited amount of drugs administered by this route is available on the market. Microneedles (MI) by their painless application appear to increase drug permeation when applied transdermally. In this review work, various types of MI (solid, coated, hollow, matrix, hydrogel forming) their size, shape, grouping, but also materials and technologies used in MI production are described. Finally, the work is focused on current clinical trials in which MI have been tested. MI with their unique properties have potential to increase the range of transdermally administered drugs currently applied by another route of administration. MI can simply pave the way for transdermal delivery to poorly penetrating small molecules as well as large molecules such as vaccines, monoclonal antibodies, or siRNA.

Keywords:

clinical trials – microneedles – materials – shape – transdermal drug delivery – vaccine delivery


Sources

1. Kirschner N., Houdek P., Fromm M., Moll I., Brandner J. M. Tight junctions form a barrier in human epidermis. Eur. J. Cell Biol. 2010; 89(11), 839–842. https://doi.org/10.1016/j.ejcb.2010.07.010

2. Andrews S. N., Jeong E., Prausnitz M. R. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm. Res. 2013; 30(4), 1099–1109. https://doi.org/10.1007/s11095-012-0946-7

3. Gaur P. K., Mishra S., Purohit S., Dave K. Transdermal Drug Delivery System: A Review RANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW. Asian J. Pharm. Clin. Res. 2009; 2(1), 14–20.

4. Nisar A., Afzulpurkar N., Mahaisavariya B., Tuantranont A. MEMS-based micropumps in drug delivery and biomedical applications. Sensors Actuators, B Chem. 2008; 130(2), 917–942. https://doi.org/10.1016/j.snb.2007.10.064

5. Ashraf M. W., Tayyaba S., Afzulpurkar N. Micro Electromechanical Systems (MEMS) based microfluidic devices for biomedical applications. Int. J. Mol. Sci. 2011; 12(6), 3648–3704. https://doi.org/10.3390/ijms12063648

6. Ita K. Transdermal delivery of drugs with microneedles – potential and challenges. Pharmaceutics. 2015; 7(3), 90–105. https://doi.org/10.1016/j.jddst.2015.05.001

7. Gill H. S., Denson D. D., Burris B. A., Prausnitz M. R. Effect of microneedle design on pain in human volunteers. Clin. J. Pain. 2008; 24(7), 585–594. https://doi.org/10.1097/AJP.0b013e31816778f9

8. Khanna P., Luongo K., Strom J. A., Bhansali S. Sharpening of hollow silicon microneedles to reduce skin penetration force. J. Micromechanics Microengineering. 2010; 20(4), 45011. https://doi.org/10.1088/0960-1317/20/4/045011

9. Gittard S. D., Chen B., Xu H., Ovsianikov A., Chichkov B. N., Monteiro-Riviere N. A., et al. The effects of geometry on skin penetration and failure of polymer microneedles. J. Adhes. Sci. Technol. 2013; 27(3), 227–243. https://doi.org/10.1080/01694243.2012.705101

10. Davis S. P., Prausnitz M. R., Allen M. G. Fabrication and characterization of laser micromachined hollow microneedles. TRANSDUCERS 2003 – 12th International Conference on Solid-State Sensors, Actuators and Microsystems, Digest of Technical Papers, vol. 2. IEEE 2003; 1435–1438.

11. Arora A., Prausnitz M. R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int. J. Pharm. 2008; 364(2), 227–236. https://doi.org/10.1016/j.ijpharm.2008.08.032

12. Han M., Hyun D. H., Park H. H., Lee S. S., Kim C. H., Kim C. A novel fabrication process for out-of-plane microneedle sheets of biocompatible polymer. J. Micromechanics Microengineering 2007; 17(6), 1184–1191. https://doi.org/10.1088/0960-1317/17/6/012

13. Chen M. C., Ling M. H., Lai K. Y., Pramudityo E. Chitosan microneedle patches for sustained transdermal delivery of macromolecules. Biomacromolecules 2012; 13(12), 4022–4031. https://doi.org/10.1021/bm301293d

14. Wilke N., Mulcahy A., Ye S. R., Morrissey A. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics J. 2005; 36(7), 650–656. https://doi.org/10.1016/j.mejo.2005.04.044

15. Jenkins D., Corrie S., Flaim C., Kendall M. High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction. RSC Adv. 2012; 2(8), 3490–3495. https://doi.org/10.1039/c2ra20153d

16. Martanto W., Davis S. P., Holiday N. R., Wang J., Gill H. S., Prausnitz M. R. Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 2004; 21(6), 947–952. https://doi.org/10.1023/B:PHAM.0000029282.44140.2e

17. Bystrova S., Luttge R. Micromolding for ceramic microneedle arrays. Microelectron. Eng. 2011; 88(8), 1681–1684. https://doi.org/10.1016/j.mee.2010.12.067

18. Ma G., Wu C. Microneedle, bio-microneedle and bio-inspired microneedle: A review. J. Control. Release 2017; 251, 11–23.

19. Miyano T., Tobinaga Y., Kanno T., Matsuzaki Y., Takeda H., Wakui M., et al. Sugar Micro Needles as Transdermic Drug Delivery System. Biomed. Microdevices 2005; 7(3), 185–188. https://doi.org/10.1007/s10544-005-3024-7

20. Paik S. J., Byun S., Lim J. M., Park Y., Lee A., Chung S., et al. In-plane single-crystal-silicon microneedles for minimally invasive microfluid systems. Sensors Actuators, A Phys. 2004; 114(2–3), 276–284. https://doi.org/10.1016/j.sna.2003.12.029

21. Sebastien H., Mcallister D. V., ALLEN M. G., Prausnitz M. R. Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery. vol. 87. Elsevier 1998; 1–3.

22. S H., P L., G H., M R., R G., W T. Genetic transformation of nematodes using arrays of micromechanical piercing structures. Biotechniques 1995; 19, 766–770.

23. Larrañeta E., Lutton R. E. M., Woolfson A. D., Donnelly R. F. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Mater. Sci. Eng. R Reports 2016; 104, 1–32.

24. Oh J. H., Park H. H., Do K. Y., Han M., Hyun D. H., Kim C. G., et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur. J. Pharm. Biopharm. 2008; 69(3), 1040–1045. https://doi.org/10.1016/j.ejpb.2008.02.009

25. Ng H. I., Fernando G. J. P., Kendall M. A. F. Induction of potent CD8+ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays. J. Control. Release 2012; 162(3), 477–484. https://doi.org/10.1016/j.jconrel.2012.07.024

26. Cormier M., Johnson B., Ameri M., Nyam K., Libiran L., Zhang D. D., et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 2004; 97(3), 503–511. https://doi.org/10.1016/j.jconrel.2004.04.003

27. Kim Y. C., Quan F. S., Compans R. W., Kang S. M., Prausnitz M. R. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J. Control. Release 2010; 142(2), 187–195. https://doi.org/10.1016/j.jconrel.2009.10.013

28. Han M., Kim D. K., Kang S. H., Yoon H. R., Kim B. Y., Lee S. S., et al. Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sensors Actuators, B Chem. 2009; 137(1), 274–280. https://doi.org/10.1016/j.snb.2008.11.017

29. Gardeniers H. J. G. E., Luttge R., Berenschot E. J. W., de Boer M. J., Yeshurun S. Y., Hefetz M., et al. Silicon micromachined hollow microneedles for transdermal liquid transport. J. Microelectromechanical Syst. 2003; 12(6), 855–862. https://doi.org/10.1109/JMEMS.2003.820293

30. Davis S. P., Martanto W., Allen M. G., Prausnitz M. R. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans. Biomed. Eng. 2005; 52(5), 909–915. https://doi.org/10.1109/TBME.2005.845240

31. Wang P. M., Cornwell M., Hill J., Prausnitz M. R. Precise microinjection into skin using hollow microneedles. J. Invest. Dermatol. 2006; 126(5), 1080–1087. https://doi.org/10.1038/sj.jid.5700150

32. Bodhale D. W., Nisar A., Afzulpurkar N. Structural and microfluidic analysis of hollow side-open polymeric microneedles for transdermal drug delivery applications. Microfluid. Nanofluidics. 2010; 8(3), 373–392. https://doi.org/10.1007/s10404-009-0467-9

33. Ovsianikov A., Chichkov B., Mente P., Monteiro-Riviere N. A., Doraiswamy A., Narayan R. J. Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int. J. Appl. Ceram. Technol. 2007; 4(1), 22–29. https://doi.org/10.1111/j.1744-7402.2007.02115.x

34. Garland M. J., Migalska K., Mahmood T. M. T., Singh T. R. R., Woolfson A. D., Donnelly R. F. Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev. Med. Devices 2011; 8(4), 459–482. https://doi.org/10.1586/erd.11.20

35. Hong X., Wei L., Wu F., Wu Z., Chen L., Liu Z., et al. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Des. Devel. Ther. 2013; 7, 945–952.

36. Demir Y. K., Metin A. Ü., Şatıroğlu B., Solmaz M. E., Kayser V., Mäder K. Poly (methyl vinyl ether-co-maleic acid) – Pectin based hydrogel-forming systems: Gel, film, and microneedles. Eur. J. Pharm. Biopharm. 2017; 117, 182–194.

37. Donnelly R. F., Singh T. R. R., Garland M. J., Migalska K., Majithiya R., McCrudden C. M., et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv. Funct. Mater. 2012; 22(23), 4879–4890. https://doi.org/10.1002/adfm.201200864

38. Yang S., Feng Y., Zhang L., Chen N., Yuan W., Jin T. A scalable fabrication process of polymer microneedles. Int. J. Nanomedicine 2012; 7, 1415–1422.

39. Gratieri T., Alberti I., Lapteva M., Kalia Y. N. Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur. J. Pharm. Sci. 2013; 50(5), 609–622. https://doi.org/10.1016/j.ejps.2013.03.019

40. Hong X., Wu Z., Chen L., Wu F., Wei L., Yuan W. Hydrogel Microneedle Arrays for Transdermal Drug Delivery. Nano-Micro Lett. 2014; 6, 191–199.

41. Kim Y. C., Park J. H., Prausnitz M. R. Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev. 2012; 64(14), 1547–1568. https://doi.org/10.1016/j.addr.2012.04.005

42. Cai B., Xia W., Bredenberg S., Engqvist H. Self-setting bioceramic microscopic protrusions for transdermal drug delivery. J. Mater. Chem. B. 2014; 2(36), 5992–5998. https://doi.org/10.1039/c4tb00764f

43. Verbaan F. J., Bal S. M., van den Berg D. J., Groenink W. H. H., Verpoorten H., Lüttge R., et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 2007; 117(2), 238–245. https://doi.org/10.1016/j.jconrel.2006.11.009

44. Chandrasekaran S., Brazzle J. D., Frazier A. B. Surface micromachined metallic microneedles. J. Microelectromechanical Syst. 2003; 12(3), 281–288. https://doi.org/10.1109/JMEMS.2003.809951

45. Martin C. J., Allender C. J., Brain K. R., Morrissey A., Birchall J. C. Low temperature fabrication of biodegradable sugar glass microneedles for transdermal drug delivery applications. J. Control. Release 2012; 158(1), 93–101. https://doi.org/10.1016/J.JCONREL.2011.10.024

46. Donnelly R. F., Morrow D. I. J., Singh T. R. R., Migalska K., McCarron P. A., O’Mahony C., et al. Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev. Ind. Pharm. 2009; 35(10), 1242–1254. https://doi.org/10.1080/03639040902882280

47. Loizidou E. Z., Williams N. A., Barrow D. A., Eaton M. J., McCrory J., Evans S. L., et al. Structural characterisation and transdermal delivery studies on sugar microneedles: Experimental and finite element modelling analyses. Eur. J. Pharm. Biopharm. 2015; 89, 224–231.

48. Lee K., Lee C. Y., Jung H. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials 2011; 32(11), 3134–3140. https://doi.org/10.1016/J.BIOMATERIALS.2011.01.014

49. Demuth P. C., Min Y., Irvine D. J., Hammond P. T. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv. Healthc. Mater. 2014; 3(1), 47–58. https://doi.org/10.1002/adhm.201300139

50. Jin J., Reese V., Coler R., Carter D., Rolandi M. Chitin Microneedles for an Easy-to-Use Tuberculosis Skin Test. Adv. Healthc. Mater. 2014; 3(3), 349–353. https://doi.org/10.1002/adhm.201300185

51. Park J. H., Allen M. G., Prausnitz M. R. Polymer microneedles for controlled-release drug delivery. Pharm. Res. 2006; 23(5), 1008–1019. https://doi.org/10.1007/s11095-006-0028-9

52. Zhang J., Wang Y., Jin J. Y., Degan S., Hall R. P., Boehm R. D., et al. Use of Drawing Lithography-Fabricated Polyglycolic Acid Microneedles for Transdermal Delivery of Itraconazole to a Human Basal Cell Carcinoma Model Regenerated on Mice. JOM. 2016; 68(4), 1128–1133. https://doi.org/10.1007/s11837-016-1841-1

53. Cha K. J., Kim T., Park S. J., Kim D. S. Simple and cost-effective fabrication of solid biodegradable polymer microneedle arrays with adjustable aspect ratio for transdermal drug delivery using acupuncture microneedles. J. Micromechanics Microengineering. 2014; 24(11), 115015. https://doi.org/10.1088/0960-1317/24/11/115015

54. Wang M., Hu L., Xu C. Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. Lab Chip. 2017; 17(8), 1373–1387. https://doi.org/10.1039/C7LC00016B

55. Kim J. Y., Han M. R., Kim Y. H., Shin S. W., Nam S. Y., Park J. H. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer’s disease. Eur. J. Pharm. Biopharm. 2016; 105, 148–55.

56. Vandeweerd C., Myers J., Coulter M., Yalcin A., Corvin J. Positives and negatives of online dating according to women 50+. J. Women Aging. 2016; 28(3), 259–270. https://doi.org/10.1007/s11095-010-0097-7

57. Demir Y. K., Akan Z., Kerimoglu O. Characterization of polymeric microneedle arrays for transdermal drug delivery. PLoS One 2013; 8(10), e77289. https://doi.org/10.1371/journal.pone.0077289

58. Lee J. W., Park J. H., Prausnitz M. R. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29(13), 2113–2124. https://doi.org/10.14219/jada.archive.2012.0208

59. Mönkäre J., Reza Nejadnik M., Baccouche K., Romeijn S., Jiskoot W., Bouwstra J. A. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery. J. Control. Release 2015; 218, 53–62.

60. Lee I. C., Lin W. M., Shu J. C., Tsai S. W., Chen C. H., Tsai M. T. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. J. Biomed. Mater. Res. – Part A. 2017; 105(1), 84–93. https://doi.org/10.1002/jbm.a.35869

61. Chen M. C., Ling M. H., Kusuma S. J. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin. Acta Biomater. 2015; 24, 106–116.

62. Sullivan S. P., Murthy N., Prausnitz M. R. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv. Mater. 2008; 20(5), 933–938. https://doi.org/10.1002/adma.200701205

63. Lee I. C., He J. S., Tsai M. T., Lin K. C. Fabrication of a novel partially dissolving polymer microneedle patch for transdermal drug delivery. J. Mater. Chem. B. 2015; 3(2), 276–285. https://doi.org/10.1039/c4tb01555j

64. Quinn H. L., Bonham L., Hughes C. M., Donnelly R. F. Design of a dissolving microneedle platform for transdermal delivery of a fixed-dose combination of cardiovascular drugs. J. Pharm. Sci. 2015; 104(10), 3490–3500. https://doi.org/10.1002/jps.24563

65. McCrudden M. T. C., Alkilani A. Z., McCrudden C. M., McAlister E., McCarthy H. O., Woolfson A. D., et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J. Control. Release 2014; 180(1), 71–80. https://doi.org/10.1016/j.jconrel.2014.02.007

66. Ochoa M., Mousoulis C., Ziaie B. Polymeric microdevices for transdermal and subcutaneous drug delivery. Adv. Drug Deliv. Rev. 2012; 64(14), 1603–1616.

67. Rodríguez A., Molinero D., Valera E., Trifonov T., Marsal L. F., Pallarès J., et al. Fabrication of silicon oxide microneedles from macroporous silicon. Sensors Actuators, B Chem. 2005; 109(1), 135–140. https://doi.org/10.1016/j.snb.2005.03.015

68. McGrath M. G., Vucen S., Vrdoljak A., Kelly A., O’Mahony C., Crean A. M., et al. Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration. Eur. J. Pharm. Biopharm. 2014; 86(2), 200–211. https://doi.org/10.1016/j.ejpb.2013.04.023

69. Lee K., Jung H. Drawing lithography for microneedles: A review of fundamentals and biomedical applications. Biomaterials. 2012; 33(30), 7309–7326. https://doi.org/10.1016/J.BIOMATERIALS.2012.06.065

70. Sharad J. Combination of microneedling and glycolic acid peels for the treatment of acne scars in dark skin. J. Cosmet. Dermatol. 2011; 10(4), 317–23. https://doi.org/10.1111/j.1473-2165.2011.00583.x

71. Garg S., Baveja S. Combination therapy in the management of atrophic acne scars. J. Cutan. Aesthet. Surg. 2014; 7(1), 18. https://doi.org/10.4103/0974-2077.129964

72. Nofal E., Helmy A., Nofal A., Alakad R., Nasr M. Platelet-rich plasma versus CROSS technique with 100% trichloroacetic acid versus combined skin needling and platelet rich plasma in the treatment of atrophic acne scars: A comparative study. Dermatologic Surg. 2014; 40(8), 864–873. https://doi.org/10.1111/dsu.0000000000000091

73. Dhurat R., Sukesh M., Avhad G., Dandale A., Pal A., Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: A pilot study. Int. J. Trichology. 2013; 5(1), 6. https://doi.org/10.4103/0974-7753.114700

74. Lee Y. B., Eun Y. S., Lee J. H., Cheon M. S., Park Y. G., Cho B. K., et al. Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: A pilot study. J. Dermatol. 2013; 40, 81–83.

75. Nanopass. A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia – Full Text View – ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT00539084?term=microneedle&rank=5. Accessed January 23, 2019.

76. Petukhova T. A., Hassoun L. A., Foolad N., Barath M., Sivamani R. K. Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: A randomized clinical trial. JAMA Dermatology 2017; 153(7), 637–643. https://doi.org/10.1001/jamadermatol.2017.0849

77. Lev-Tov H., Larsen L., Zackria R., Chahal H., Eisen D. B., Sivamani R. K. Microneedle-assisted incubation during aminolaevulinic acid photodynamic therapy of actinic keratoses: a randomized controlled evaluator-blind trial. Br. J. Dermatol. 2017; 176(2), 543–545. https://doi.org/10.1111/bjd.15116

78. Miteva M., Lima M., Tosti A. Effect of microneedle pretreatment on topical anesthesia: A randomized clinical trial association of dermatology consultation with accuracy of cutaneous disorder diagnoses in hospitalized patients: A multicenter analysis limited information exists on th. JAMA Dermatology. 2016; 152(4), 476–477. https://doi.org/10.1001/jamadermatol.2015.5545

79. Bhatnagar S., Dave K., Venuganti V. V. K. Microneedles in the clinic. J. Control. Release. 2017; 260, 164–182.

80. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26(51), 6614–6619. https://doi.org/10.1016/j.vaccine.2008.09.078

81. Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M. P., Weber F., et al. Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study. Vaccine. 2009; 27(52), 7304–7312. https://doi.org/10.1016/j.vaccine.2009.10.033

82. Morelon E., Noble C. P., Daoud S., Cahen R., Goujon-Henry C., Weber F., et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010; 28(42), 6885–6890. https://doi.org/10.1016/j.vaccine.2010.08.015

83. European Medicines Agency. Intanza Withdrawal of the marketing authorisation in the European Union. Available at: https://www.ema.europa.eu/documents/public-statement/public-statement-intanza-withdrawal-marketing-authorisation-european-union_en.pdf. Accessed January 30, 2019.

84. European Medicines Agency. IDflu Withdrawal of the marketing authorisation in the European Union. Available at: https://www.ema.europa.eu/documents/public-statement/public-statement-idflu-withdrawal-marketing-authorisation-european-union_en.pdf. Accessed January 30, 2019.

85. Troy S. B., Kouiavskaia D., Siik J., Kochba E., Beydoun H., Mirochnitchenko O., et al. Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults. J. Infect. Dis. 2015; 211(12), 1969–1976. https://doi.org/10.1093/infdis/jiu841

86. Seventieth World Health Assembly. Poliomyelitis. Report by the Secretariat. WHO 2017; 1–18.

87. Norman J. J., Brown M. R., Raviele N. A., Prausnitz M. R., Felner E. I. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr. Diabetes. 2013; 14(6), 459–465. https://doi.org/10.1111/pedi.12031

88. Gupta J., Felner E. I., Prausnitz M. R. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol. Ther. 2011; 13(4), 451–456. https://doi.org/10.1089/dia.2010.0204

89. Glucagon Z. P., Represents P. Zosano Pharma Announces Positive Phase 2 Results for Its ZP Glucagon Patch Program for Treatment of Severe Hypoglycemia 2016.

90. Yates J., Miller P. D., Bolognese M. A., Woodson G., Valter I., Clarkin M., et al. A transdermal patch delivering the PTHrP1-34 analog, abaloparatide (BA058), dose-dependently increases spine and hip BMD compared to placebo. Endocr. Rev. 2014; 35.

91. Kellerman D. J., Ameri M., Tepper S. J. Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray. Pain Manag. 2017; 7(6), 559–567. https://doi.org/10.2217/pmt-2017-0036

92. Spierings E. L. H., Brandes J. L., Kudrow D. B., Weintraub J., Schmidt P. C., Kellerman D. J., et al. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine. Cephalalgia 2018; 38(2), 215–224. https://doi.org/10.1177/0333102417737765

93. Leung D. Y. M., Jepson B., Beck L. A., Hanifin J. M., Schneider L. C., Paller A. S., et al. A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2017; 139(5), 1575–1582.e8. https://doi.org/10.1016/j.jaci.2016.12.952

94. Saroha K., Yadav B., Sharma B. Transdermal patch: A discrete dosage form. Int. J. Curr. Pharm. Res. 2011; 3(3), 98–108.

95. Donnelly R. F., Larrañeta E. Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. Drug Discov. Today 2018; 23(5), 1026–1033. https://doi.org/10.1016/J.DRUDIS.2017.10.013

96. Gerstel M., VA Place – US Patent 3 964,482., 1976 undefined. Drug delivery device. Google Patents. n.d

Labels
Pharmacy Clinical pharmacology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#